Skip to main content
SpringerLink
Log in

The role of jo-1 in the immunopathogenesis of polymyositis: Current hypotheses

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Polymyositis represents an autoimmune disease in which T cells mediate destruction of muscle cells. Although the precise trigger(s) for this process remain unknown, distinct clinical subsets exist that are characterized by antibodies directed against specific nuclear and cytoplasmic antigens including Jo-1 (histidyl-transfer RNA synthetase). Coupled with a range of genetic and histomorphologic data, the stereotypical serologic response suggests that antigen-specific T cells directed against Jo-1 can promote T cell-mediated cytolysis of muscle cells as well as anti-Jo-1 antibody formation in selected patients with polymyositis. Beyond a previously developed animal model that has demonstrated the capacity of Jo-1 to promote humoral and cell-mediated immune responses leading to myositis, recent studies have revealed the existence of Jo-1-specific T cells in the peripheral blood of patients with Jo-1 antibody-positive polymyositis. Even more striking, investigators have discovered that Jo-1 can serve as a chemokine for immature dendritic cells and T lymphocytes. Collectively, these findings suggest a mechanism by which Jo-1 can bridge the innate and adaptive immune responses, leading to the breakdown of tolerance and autoimmune destruction of muscle.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Oddis CV: Idiopathic inflammatory myopathies. In Clinical Disorders of Skeletal Muscle. Edited by Wortmann RL. Philadelphia: Lippincott-Raven Press; 1999:45–87.

    Google Scholar 

  2. Dalakas MC, Sivakumar K: The immunopathologic and inflammatory differences between dermatomyositis, polymyositis and sporadic inclusion body myositis. Curr Opin Neurol 1996, 9:235–239.

    Article  PubMed  CAS  Google Scholar 

  3. Kissel JT, Mendell JR, Rammohan KW: Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 1986, 314:329–334.

    Article  PubMed  CAS  Google Scholar 

  4. Emslie-Smith AM, Engel AG: Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol 1990, 27:343–356.

    Article  PubMed  CAS  Google Scholar 

  5. Targoff IN: Humoral immunity in polymyositis/dermatomyositis. J Invest Dermatol 1993, 100:116S-123S.

    Article  PubMed  CAS  Google Scholar 

  6. Cherin P, Herson S, Crevon MC, et al.: Mechanisms of lysis by activated cytotoxic cells expressing perforin and granzyme-B genes and the protein TIA-1 in muscle biopsies of myositis. J Rheum 1996, 23:1135–1142.

    PubMed  CAS  Google Scholar 

  7. Behrens L, Bender A, Johnson MA, Hohlfeld R: Cytotoxic mechanisms in inflammatory myopathies: co-expression of Fas and protective Bcl-2 in muscle fibers and inflammatory cells. Brain 1997, 120:929–938.

    Article  PubMed  Google Scholar 

  8. Sugiura T, Murakawa Y, Nagai A, et al.: Fas and Fas ligand interaction induces apoptosis in inflammatory myopathies. Arthritis Rheum 1999, 42:291–298.

    Article  PubMed  CAS  Google Scholar 

  9. Choi YC, Dalakas MC: Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies. Neurology 2000, 54:65–70.

    PubMed  CAS  Google Scholar 

  10. Tateyama M, Nagano I, Yoshioka M, et al.: Expression of tumor necrosis factor-alpha in muscles of polymyositis. J Neurol Sci 1997, 146:45–51.

    Article  PubMed  CAS  Google Scholar 

  11. Kuru S, Inukai A, Liang Y, et al.: Tumor necrosis facor-alpha expression in muscles of polymyositis and dermatomyositis. Acta Neuropathol 2000, 99:585–588.

    Article  PubMed  CAS  Google Scholar 

  12. Miller FW, Waite KA, Biswas T, Plotz PH: The role of an autoantigen, histidyl-tRNA synthetase, in the induction and maintenance of autoimmunity. Proc Natl Acad Sci U S A 1990, 87:9933–9937. Through analysis of the anti-Jo-1 antibody response in a patient with myositis at the onset of disease, this study demonstrates the process of affinity maturation indicative of an immune response driven by human histidyl-transfer RNA synthetase (Jo-1) rather than crossreactivity to foreign proteins.

    Article  PubMed  CAS  Google Scholar 

  13. Miller FW, Twitty SA, Biswas T, Plotz PH: Origin and regulation of a disease-specific autoantibody response. J Clin Invest 1990, 85:468–475.

    PubMed  CAS  Google Scholar 

  14. Raben N, Nichols R, Dohlman J, et al.: A motif in human histidyl-tRNA synthetase which is shared among several aminoacyl-tRNA synthetases is a coiled-coil that is essential for enzymatic activity and contains the major autoantigenic epitope. J Biol Chem 1994, 269:24277–24283. Although from 1994, this work localized the major B cell epitope recognized by anti-Jo-1 human sera to the amino-terminal 47 amino acids of histidyl-transfer RNA synthetase. Later work by Casciola- Rosen et al. [36] demonstrated a granzyme B cleavage site at amino acid 48 of histidyl-transfer RNA synthetase.

    PubMed  CAS  Google Scholar 

  15. Martin A, Shulman MJ, Tsui FW: Epitope studies indicate that histidyl-tRNA synthetase is a stimulating antigen in idiopathic myositis. FASEB J 1995, 9:1226–1233.

    PubMed  CAS  Google Scholar 

  16. Craft J, Fatenejad S: Self antigens and epitope spreading in systemic autoimmunity. Arthritis Rheum 1997, 40:1374–1382.

    Article  PubMed  CAS  Google Scholar 

  17. Kita H, Matsumura S, He XS, et al.: Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest 2002, 109:1231–1240. Using pyruvate dehydrogenase complex-E2 (PDC-E2) peptide-pulsed dendritic cells, the investigators were able to amplify peptide-specific CD8+ T cells from peripheral blood as well as liver-infiltrating lymphocyte populations in patients with primary biliary cirrhosis. Because CD4+ T cells and B cells from these patients recognize the same antigen (PDC-E2), this human disease provides a paradigm for the proposed role of Jo-1 in directing the humoral and cell-mediated immune responses of PM.

    Article  PubMed  CAS  Google Scholar 

  18. Akbar S, Yamamoto K, Miyaki H, et al.: Peripheral blood T-cell responses to pyruvate dehydrogenase complex in primary biliary cirrhosis: role of antigen-presenting dendritic cells. Eur J Clin Invest 2001, 31:639–646.

    Article  PubMed  CAS  Google Scholar 

  19. Yeaman S, Kirby J, Jones D: Autoreactive responses to pyruvate dehydrogenase complex in the pathogenesis of primary biliary cirrhosis. Immunol Rev 2000, 174:238–249.

    Article  PubMed  CAS  Google Scholar 

  20. Palmer J, Diamond A, Yeaman S, et al.: T cell responses to the putative dominant autoepitope in primary biliary cirrhosis (PBC). Clin Exp Immunol 1999, 116:133–139.

    Article  PubMed  CAS  Google Scholar 

  21. Blechynden LM, Lawson MM, Tabarias H, et al.: Myositis induced by naked DNA immunization with the gene for histidyl-tRNA synthetase. Hum Gene Ther 1997, 8:1469–1480. Through DNA immunization of mice with the histidyl-transfer RNA synthetase gene, the authors were able to demonstrate Jo-1 autoantibody formation as well as localized myositis. This animal model therefore supports a direct role for Jo-1 in the pathogenesis of myositis.

    PubMed  CAS  Google Scholar 

  22. Nagaraju K, Raben N, Loeffler L, et al.: Conditional upregulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific antibodies. Proc Natl Acad Sci USA 2000, 97:9209–9214. This work describes a murine model of spontaneous PM resulting from inducible, tissue-specific upregulation of MHC class I expression. Characterized by predominant macrophage or monocyte infiltration of muscle as well as autoantibody formation, this experimental model suggests a potential mechanism for the breadown of tolerance leading to inflammatory muscle disease in humans.

    Article  PubMed  CAS  Google Scholar 

  23. O’Hanlon TP, Dalakas MC, Plotz PH, Miller FW: Predominant TCR-ab variable and joining gene expression by muscleinfiltrating lymphocytes in the idiopathic inflammatory myopathies. J Immunol 1994, 152:2569–2576.

    PubMed  CAS  Google Scholar 

  24. Bender A, Ernst N, Iglesias A, et al.: T cell receptor repertoire in polymyositis: clonal expansion of autoaggressive CD8+ T cells. J Exp Med 1995, 181:1863–1868. By demonstrating oligoclonal T cell expansion in muscle biopsy specimens from patients with PM, this analysis provides compelling evidence that this disease process is antigen driven.

    Article  PubMed  CAS  Google Scholar 

  25. Kuwana M, Medsger TA, Jr., Wright TM: T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors. J Clin Invest 1995, 6:586–596.

    Google Scholar 

  26. Kuwana M, Medsger TA Jr., Wright TM: Highly restricted TCRalpha/ beta usage by autoreactive human T cell clones specific for DNA topoisomerase I. J Immunol 1997, 158:485–491.

    PubMed  CAS  Google Scholar 

  27. Kuwana M, Medsger TA, Jr., Wright TM: Analysis of soluble and cell surface factors regulating anti-DNA topoisomerase I autoantibody production demonstrates synergy between Th1 and Th2 autoreactive T cells. J Immunol 2000, 164:6138–6146.

    PubMed  CAS  Google Scholar 

  28. Hattori N, Kuwana M, Kaburaki J, et al.: T cells that are autoreactive to beta-2-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals. Arthritis Rheum 2000, 43:65–75.

    Article  PubMed  CAS  Google Scholar 

  29. Kuwana M, Kaburaki J, Ikeda Y: Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. J Clin Invest 1998, 102:1393–1402.

    Article  PubMed  CAS  Google Scholar 

  30. Goldstein R, Duvic M, Targoff IN, et al.: HLA-D region genes associated with autoantibody responses to histidyl-tRNA synthetase (Jo-1) and other translation-related factors in myositis. Arthritis Rheum 1990, 33:1240–1248.

    Article  PubMed  CAS  Google Scholar 

  31. Arnett FC, Targoff IN, Mimori T, et al.: Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. Arthritis Rheum 1996, 39:1507–1518.

    Article  PubMed  CAS  Google Scholar 

  32. Garlep MJ: Genetics of the idiopathic inflammatory myopathies. Curr Opin Rheumatol 1996, 8:514–520.

    Article  Google Scholar 

  33. Ascherman D, Oriss T, Oddis CV, Wright TM: Critical requirement for professional APCs in eliciting T cell responses to novel fragments of histidyl-tRNA synthetase (Jo-1) in Jo-1 antibody-positive polymyositis. J Immunol 2002, 169:7127–7134. This work represents the first demonstration of Jo-1-specific T cell responses in patients with Jo-1 antibody PM as well as healthy control individuals. Analysis of proliferative responses to fragments of Jo-1 presented by dendritic cells reveals an immudominant T cell epitope contained within the amino terminal 150 amino acids of this protein.

    PubMed  CAS  Google Scholar 

  34. O’Hanlon TP, Miller FW: Genomic organization, transcriptional mapping, and evolutionary implications of the human bi-directional histidyl-tRNA synthetase locus (HARS/ HARSL). Biochem Biophys Res Commun 1995, 294:609–614.

    Article  CAS  Google Scholar 

  35. Rosen A, Casciola-Rosen L: Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ 1999, 6:6–12. This review describes the potential autoantigenic role of “cryptic” epitopes generated through cleavage of selected proteins by proteases activated during apoptosis.

    Article  PubMed  CAS  Google Scholar 

  36. Casciola-Rosen L, Andrade F, Ulanet D, et al.: Cleavage by granzyme B is strongly predictive of autoantigen status: implications for the initiation of autoimmunity. J Exp Med 1999, 190:815–826. This work provides strong evidence that seemingly disparate autoantigens share the common feature of granzyme B-cleavability. Elaborated during cytotoxic lymphocyte-mediated cell death, this enzyme is capable of generating novel epitopes that may contribute to the breakdown of tolerance and generation of autoimmunity.

    Article  PubMed  CAS  Google Scholar 

  37. Utz P, Anderson P: Postranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens. Arthritis Rheum 1998, 41:1152–1160. This review nicely summarizes how alterations in antigenic structure during apoptosis can result in tolerance breakdown.

    Article  PubMed  CAS  Google Scholar 

  38. Wakasugi K, Schimmel P: Two distinct cytokines released from a human aminoacyl-tRNA synthetase. Science 1999, 284:147–151. In a novel set of experiments suggested by analysis of the domain structure of tyrosyl-transfer RNA synthetase, these authors demonstrate functional cytokine properties for amino- and carboxy-terminal fragments of this enzyme.

    Article  PubMed  CAS  Google Scholar 

  39. Wakasugi K, Slike B, Hood J, et al.: A human aminoacyl-tRNA synthetase as a regulator of angiogenesis. Proc Natl Acad Sci U S A 2002, 99:173–177.

    Article  PubMed  CAS  Google Scholar 

  40. Nagaraju K: Immunological capabilities of skeletal muscle cells. Acta Physiol Scand 2001, 171:215–223.

    Article  PubMed  CAS  Google Scholar 

  41. Howard OMZ, Dong HF, Yang D, et al.: Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells. J Exp Med 2002, 196:781–791. This study extends earlier work regarding non-enzymatic biologic functions of aminoacyl-transfer RNA synthetases, demonstrating chemokine properties of Jo-1. Because Jo-1 interacts with chemokine receptors on immature dendritic cells as well as T cells, the authors speculate that Jo-1 may be able to link the innate and adaptive immune response in PM.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology and Clinical Immunology, University of Pittsburgh, S707 Biomedical Science Tower, 15261, Pittsburgh, PA, USA

    Dana P. Ascherman MD

Authors
  1. Dana P. Ascherman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ascherman, D.P. The role of jo-1 in the immunopathogenesis of polymyositis: Current hypotheses. Curr Rheumatol Rep 5, 425–430 (2003). https://doi.org/10.1007/s11926-003-0052-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-003-0052-2

Keywords

Search

Navigation